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The mechanism by which hamsters acquire resistance to yaws or frambesia is poorly understood. This investigation has shown that immune lymphoid cells (spleen and lymph node) could confer on hamsters resistance to infection with Treponema pertenue. Treatment of these immune cells with a specific antithymocyte serum (ATS) inhibited the transfer of resistance. Twenty-one days after infection, recipients of immune cells treated with ATS had cutaneous lesions, in contrast to recipients of immune cells treated with normal rabbit serum. Treatment of immune cells with ATS, however, did not completely abolish resistance to treponemal infection. The weight and number of treponemes in the lymph nodes of recipients were significantly lower than those infused with normal cells treated with ATS or normal rabbit serum. The specificity of the ATS was demonstrated by its failure to inhibit functional antibody-producing cells and its high cytotoxic activity for thymocytes. These results present direct evidence that ATS-sensitive cells are involved in resistance to frambesial infection.
The immune mechanism by which hamsters acquire resistance to Treponema pertenue, the causative agent of frambesia or yaws, is poorly understood. Hamsters infected with T. pertenue develop extensive chronic skin lesions that persist for more than 6 months (4, 6), but frambesial hamsters treated with penicillin several months after infection are resistant to reinfection (10) . Lymphoid cells obtained from these immune hamsters can confer on normal recipients protection from infection with T. pertenue (10) .
The successful transfer of resistance with immune cells, however, does not clarify the role of T-cell-mediated immunity in frambesial infection. The transferred immune cells might contain a population of cells which produce effective treponemicidal antibodies. The purpose of this investigation was to determine the ability of frambesial immune cells treated with anti-thymocyte serum (ATS) to adoptively transfer resistance to infection with T. pertenue. The inability of ATS-treated frambesial immune cells to confer resistance on normal recipients would provide evidence that T-cell-mediated immunity is involved in resistance to frambesial infection. Effect of ATS on plaque forming cells. Penicillin-treated frambesial hamsters were inoculated intravenously and subcutaneously at weekly intervals with 109 SRBC for 2 weeks. Five days after the second inoculation of SRBC, a pooled suspension of spleen and lymph node cells was treated with NRS or ATS and complement. The number of plaque-forming cells was determined by the hemolytic plaque technique in gel. The method to determine the number of direct and indirect plaque-forming cells has been previously described (8) .
MATERIALS AND METHODS

Animals
Serological test. The Sera-Tek treponemal antibody test (MHA-TP) was obtained from Ames Co. (Elkhart, Ind.). The MHA-TP test is manufactured by Fujizoki Pharmaceutical Co., Ltd., Shinjuku-ku, Tokyo, Japan. The test was performed as described by the manufacturer with one exception. Sera obtained from frambesial hamsters were serially diluted with absorbing diluent to obtain quantitative titers.
Experimental design and statistical analysis. Experiments were performed in a double-blind fashion, and the principles of randomization were used in the assignment of animals to cages, treatment groups, etc. The analysis of variance was used. The Fisher least significant difference test (11) was used to examine pairs of means when a significant F ratio indicated reliable mean differences. The alpha level was set at 0.05 before the initiation of the experiments. nodes when compared with the normal cell donors and the remaining group of recipients, respectively. Recipients of immune cells treated with ATS, however, were partially resistant to treponemal infection. The weight and number of treponemes in the lymph nodes of ATStreated immune cell recipients were significantly lower than those of the recipients of normal cells treated with NRS or ATS. These results suggest that treatment of immune cells with ATS did not inhibit all cells capable of transferring resistance.
RESULTS
Inability of ATS-treated immune cells
Specificity of ATS. To confirm the specificity of the ATS, hamsters resistant to frambesial infection were injected subcutaneously and intravenously with a total of 2 x 109 SRBC on days 0 and 7. On day 12 the number of spleen and lymph node cells from infected hamsters forming antibodies to SRBC after treatment with ATS or NRS and complement was determined. Although the viability of the ATStreated cells decreased, there were no significant differences in the number of direct or indirect plaques formed by these cells after treatment with either NRS or ATS ( Table 2) .
Effect of ATS treatment on specific treponemal antibody production. Twenty-one days after treponemal infection the MHA-TP titer was determined for the recipients of immune and normal cells treated with ATS or NRS. Recipients of immune cells treated with ATS had an eightfold reduction in antibody titer when compared with recipients of immune cells treated with NRS (Table 3) . ATS treatment had a similar effect on the development of treponemal antibodies in recipients of normal cells.
DISCUSSION
We have shown previously (10) that cells obtained from hamsters resistant to frambesial in- (3, 9) . We observed a fourfold or greater reduction in the MHA-TP antibody titer in recipients of normal or immune cells treated with ATS compared with those that received cells treated with NRS (Table 3) . These results suggest that the MHA-TP antibody titer is dependent upon ATS-sensitive cells. Treatment of frambesial immune or normal cells with ATS may have resulted in the depletion of helper Tcells which are needed for the development of MHA-TP antibody. Treatment with ATS may have also depleted helper T-cells that regulate the development of other antibodies that may be more closely associated with protection than the MHA-TP antibody. We have shown previously that immune serum can transfer resistance to infection with T. pertenue (10) . Treatment of immune cells with ATS may have inhibited the development of protective antibodies in recipients by removal of helper T-cells.
The immune response of the hamster to frambesial infection is complex. Serum or cells obtained from immune hamsters could confer protection on recipient hamsters challenged with T. pertenue (10) . This investigation has shown that treatment of immune cells with ATS inhibited the transfer of resistance and influenced the development of the MHA-TP antibody. Since thymus-derived cells can regulate antibody development (3, 9) and other T-cellmediated functions (1), additional experiments are needed to identify the mechanisms) by which ATS-sensitive cells are involved in the transfer of resistance to frambesial infection.
